stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Urogen Pharma LtdURGN
$29.9412.98%-4.465

Urogen Pharma Ltd (URGN)

Date: 2026-11-04 16:00O: 33.04H: 34.17L: 27.55C: 29.97Vol: 1.530M
Precedente Chiudi:
$34.40
Aprire:
$33.04
Volume 24 ore:
1,169,599
Volume relativo:
1.03
Capitalizzazione di mercato:
$1.46B
Reddito:
$140.49M
Utile/perdita netta:
-$153.49M
Rapporto P/E:
-
EPS:
-$2.76
Flusso di cassa netto:
-$175.90M
1W Prestazione:
-11.30%
1M Prestazione:
-27.69%
6M Prestazione:
+28.53%
1Y Prestazione:
+51.11%
Intervallo 1D:
$27.55$34.17
Intervallo di 1 settimana:
$32.39$34.97
Portata 52W:
$16.50$50.81

Profilo aziendale di Urogen Pharma Ltd (URGN)

Nome
Urogen Pharma Ltd
Settore
Healthcare
Industria
Biotechnology
Telefono
972 9 770 7601
Indirizzo
9 HA'TA'ASIYA ST, RA'ANANA, USA
Dipendente
291
Prossima data di guadagno
2026-11-04
Ultimi documenti SEC
SEC
Discussioni di URGN su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Urogen Pharma Ltd Azioni (URGN) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-05-11ResumedLadenburg ThalmannBuy
2026-04-10IniziatoJefferiesBuy
2025-08-19IniziatoPiper SandlerOverweight
2025-06-16AggiornamentoH.C. WainwrightNeutral → Buy

Urogen Pharma Ltd Azioni (URGN) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)109.7990.4082.7164.3648.04
Cost of revenue USD (M)12.458.889.367.655.16
Gross profit USD (M)97.3481.5273.3556.7042.89
Research and development USD (M)67.1157.1545.6152.9147.64
Operating expenses USD (M)--138.89135.74135.18
Operating income USD (M)-124.86-96.78-65.54-79.04-92.29
Income before tax USD (M)-153.42-124.04-98.32-108.03-109.37
Income tax expense USD (M)0.082.833.921.761.45
Net income USD (M)-153.49-126.87-102.24-109.78-110.82
Basic EPS USD/shares-3.19-2.96-3.55-4.81-
Basic weighted shares shares (M)48.1242.8828.8322.81-
Selling, general and administrative USD (M)155.10121.1593.2782.8487.54

Urogen Pharma Ltd Azioni (URGN) insider trading

  • Officer
    Transazione
    Proposed Sale
    Costo
    $40.70
    #Azioni
    2,202
    Valore ($)
    89,621
    #Azioni Totale
    0
  • Degnan ChrisOct 08 '26
    Chief Financial Officer
    Transazione
    Sale
    Costo
    $36.69
    #Azioni
    2,202
    Valore ($)
    80,791
    #Azioni Totale
    4,561
  • General Counsel
    Transazione
    Sale
    Costo
    $42.54
    #Azioni
    1,519
    Valore ($)
    64,618
    #Azioni Totale
    53,141
  • Schoenberg MarkSep 08 '26
    Chief Medical Officer
    Transazione
    Sale
    Costo
    $42.92
    #Azioni
    871
    Valore ($)
    37,383
    #Azioni Totale
    59,882
  • Jason SmithSep 08 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $44.09
    #Azioni
    1,519
    Valore ($)
    66,973
    #Azioni Totale
    0
  • Mark SchoenbergSep 08 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $44.09
    #Azioni
    871
    Valore ($)
    38,402
    #Azioni Totale
    0
  • Schoenberg MarkAug 20 '26
    Chief Medical Officer
    Transazione
    Sale
    Costo
    $47.05
    #Azioni
    60,677
    Valore ($)
    2,854,853
    #Azioni Totale
    59,086
  • Schoenberg MarkAug 20 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $47.67
    #Azioni
    60,677
    Valore ($)
    2,892,242
    #Azioni Totale
    0
  • Schoenberg MarkJul 09 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $40.00
    #Azioni
    10,000
    Valore ($)
    400,008
    #Azioni Totale
    0
  • Schoenberg MarkJul 09 '26
    Chief Medical Officer
    Transazione
    Sale
    Costo
    $40.00
    #Azioni
    10,000
    Valore ($)
    400,000
    #Azioni Totale
    119,763
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Christopher DegnanOfficerOct 08 '26Proposed Sale$40.702,20289,6210
Degnan ChrisChief Financial OfficerOct 08 '26Sale$36.692,20280,7914,561
Smith Jason DrewGeneral CounselSep 08 '26Sale$42.541,51964,61853,141
Schoenberg MarkChief Medical OfficerSep 08 '26Sale$42.9287137,38359,882
Jason SmithOfficerSep 08 '26Proposed Sale$44.091,51966,9730
Mark SchoenbergOfficerSep 08 '26Proposed Sale$44.0987138,4020
Schoenberg MarkChief Medical OfficerAug 20 '26Sale$47.0560,6772,854,85359,086
Schoenberg MarkOfficerAug 20 '26Proposed Sale$47.6760,6772,892,2420
Schoenberg MarkOfficerJul 09 '26Proposed Sale$40.0010,000400,0080
Schoenberg MarkChief Medical OfficerJul 09 '26Sale$40.0010,000400,000119,763

Urogen Pharma Ltd Borsa (URGN) Ultime notizie

Nov 02, 2026
Nov 02, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 18, 2026
Oct 18, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Sep 30, 2026
Sep 30, 2026
Sep 23, 2026
Sep 23, 2026
Sep 23, 2026
Sep 23, 2026
Sep 12, 2026
Sep 12, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 05, 2026
Sep 05, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026

Simile a URGN